Aurora Cannabis Inc trades with the ticker ACB on the TSX and is in the Drug Manufacturers – Specialty & Generic industry.
Overview
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company’s adult-use brand portfolio includes Aurora Drift, San Rafael ’71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Looking to invest in Aurora Cannabis Inc? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.
Table of Contents
show
ACB.TO Stock Price and Key Stats
ETF Key Stats
Exchange: TSX
Market Cap : $222.521MM
PE Ratio:
Price: 3.02 (Updated: 3/12/2024 0:47:16)
Aurora Cannabis Inc (ACB) vs Competitors in Drug Manufacturers – Specialty & Generic
Lets see how ACB.TO stacks up against others in the Drug Manufacturers – Specialty & Generic asset management industry. We have identified its main peers as:Avicanna Inc, Bausch Health Companies Inc, Cardiol Therapeutics Inc, Cronos Group Inc, Charlotte’s Web Holdings, Inc
.Drug Manufacturers – Specialty & Generic Industry Comparisons
| Company | Market Cap ($MM) | P/E Ratio | EV/EBITDA | Dividend Yield |
|---|---|---|---|---|
| Aurora Cannabis Inc (ACB) | $222.521 | N/A | -0.115 | N/A% |
| Avicanna Inc (AVCN) | $43.759 | N/A | -4.217 | N/A% |
| Bausch Health Companies Inc (BHC) | $4,553.034 | N/A | 15.169 | N/A% |
| Cardiol Therapeutics Inc (CRDL) | $132.181 | N/A | -3.0 | N/A% |
| Cronos Group Inc (CRON) | $1,018.068 | N/A | 1.918 | N/A% |
EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield
Comparisons within Drug Manufacturers – Specialty & Generic
- Aurora Cannabis Inc (ACB) vs Avicanna Inc (AVCN)
- AVCN has higher EPS (-0.17 vs -79.2). AVCN and ACB both have P/E’s under 0.
- Aurora Cannabis Inc (ACB) vs Bausch Health Companies Inc (BHC)
- BHC has higher EPS (-2.18 vs -79.2). BHC and ACB both have P/E’s under 0.
- Aurora Cannabis Inc (ACB) vs Cardiol Therapeutics Inc (CRDL)
- CRDL has higher EPS (-0.43 vs -79.2). CRDL and ACB both have P/E’s under 0.
- Aurora Cannabis Inc (ACB) vs Cronos Group Inc (CRON)
- CRON has higher EPS (-0.24 vs -79.2). CRON and ACB both have P/E’s under 0.
- Aurora Cannabis Inc (ACB) vs Charlotte’s Web Holdings, Inc (CWEB)
- CWEB has higher EPS (-0.44 vs -79.2). CWEB and ACB both have P/E’s under 0.
Our Recommendation: Hold
Shows positive EPS growth from this year to next, suggesting improving profitability. Features a lower EV/EBITDA ratio (-0.12) than the industry average (0.33), indicating attractive valuation.
How to Buy ACB stock on the TSX
You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:| Image | Product Title | Features | Price |
|---|---|---|---|
Editor's Choice  |
| Get $25 Signup Bonus | |
Reliable Pick  |
| Get $50 Free Stock Trades |
